NYSE:DFT (DFT) (DFT) Stock Price, News & Analysis → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free DFT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$66.31▼$66.3150-Day Range N/A52-Week Range$37.54▼$69.33VolumeN/AAverage Volume883,602 shsMarket CapitalizationN/AP/E Ratio29.47Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (DFT) alerts: Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> About (DFT) Stock (NYSE:DFT)DuPont Fabros Technology, Inc. (DFT) is a real estate investment trust (REIT). The Company owns, acquires, develops and operates wholesale data centers. The Company's customers include national and international enterprises across various industries, such as technology, Internet, content providers, cloud providers, media, communications, healthcare and financial services. Its data centers are located in four population centers: Northern Virginia; suburban Chicago, Illinois; Piscataway, New Jersey, and Santa Clara, California. As of December 31, 2016, the Company owned various properties, including 11 operating data centers facilities; five phases of existing data center facilities under development; one shell of a data center under development; two data center facilities with a phase or phases available for development, and parcels of land held for development of four data centers. As of December 31, 2016, the Company's 11 data centers had a total of 3.3 million gross square feet.Read More Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> DFT Stock News HeadlinesMay 8, 2024 | dailymail.co.ukHow homes inside Sadiq Khan's controversial LTNs cost up to 108% more than homes outside low-traffic neighbourhoodsMay 8, 2024 | msn.com'Progress at last' - Sadiq Khan welcomes reports Government could pay for £1bn Euston HS2 tunnelMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.May 8, 2024 | msn.comProperties inside London's LTNs are worth up to 108% more than outsideMay 8, 2024 | msn.comHS2 ‘will finish at Euston’ – but it’ll cost taxpayers another billionMay 8, 2024 | msn.comWhy are police not doing their jobs and tackling burglaries?May 7, 2024 | uk.news.yahoo.comYork and North Yorkshire train firms seek dragonsMay 7, 2024 | msn.comMassive congestion-busting plans to improve transport links across SomersetMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.May 7, 2024 | msn.comTrain driver strikes cause disruptionMay 7, 2024 | msn.comTrain strikes to restart sparking anger from City bodies and hospitality groupsMay 6, 2024 | msn.comMXene-Supported PtCo Catalysts for Hydrogen EvolutionMay 6, 2024 | msn.comTeam describes MXene-supported PtCo bimetallic catalyst for hydrogen evolution in acidic conditionsMay 6, 2024 | msn.comPublic notices in the Liverpool City RegionMay 6, 2024 | msn.comThe Welsh Government spends £160m on a rail line it's not responsible forMay 4, 2024 | msn.comTaunton bus fares to rise from June despite rising passenger numbersMay 3, 2024 | mirror.co.ukBritain's most dangerous area to drive in outside of London revealed - is yours on the list?May 3, 2024 | msn.comTaunton bus fares to rise from June 1 despite rising passenger numbersMay 2, 2024 | uk.news.yahoo.comFull stream ahead for new Somerset railway station as 200 new homes and access road approvedMay 2, 2024 | msn.comCouncils aren't supporting the switch to EVs, voters say as elections arriveMay 2, 2024 | msn.comTeenage car deaths prompts warning from coronerMay 1, 2024 | msn.comElectric scooters: ‘Inevitability’ about legal use in Scotland with possible trial, says transport secretary Fiona HyslopApril 30, 2024 | venturebeat.comSepion Advances EV Battery Safety with AI-Driven Non-Flammable ElectrolyteApril 30, 2024 | msn.comTreasury ‘pressure’ led to cycling and walking funding cuts, High Court toldApril 30, 2024 | theguardian.comCuts to England’s cycling and walking budget challenged in courtApril 30, 2024 | msn.comBibby Marine signs shipbuilding deal for net zero vesselApril 29, 2024 | msn.comAdequately stabilized and exposed Cu/CuₓO heterojunction on porous carbon nanofibersSee More Headlines Receive DFT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (DFT) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/28/2016Today5/08/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryOffice REITs Current SymbolNYSE:DFT CUSIP26613Q10 CIK1407739 Webwww.dft.com Phone+1-202-7280044FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio29.47 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesLammot J. du PontChairman of the BoardChristopher P. EldredgePresident, Chief Executive Officer, DirectorJeffrey H. FosterChief Financial Officer, Executive Vice President, TreasurerScott A. DavisExecutive Vice President, Chief Technology OfficerRichard A. Montfort Jr.Executive Vice President, General Counsel, SecretaryMaria KennyExecutive Vice President, Chief Development OfficerJames W. ArmstrongSenior Vice President, Chief Accounting OfficerJohn T. Roberts Jr.Lead Independent DirectorMichael A. Coke CPAIndependent DirectorThomas D. EckertIndependent DirectorMore Executives DFT Stock Analysis - Frequently Asked Questions How were (DFT)'s earnings last quarter? (DFT) (NYSE:DFT) posted its quarterly earnings results on Thursday, July, 28th. The real estate investment trust reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by $0.01. The real estate investment trust earned $128.54 million during the quarter, compared to analyst estimates of $127.15 million. The firm's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.62 EPS. Is (DFT) a good dividend stock? (DFT) (NYSE:DFT) pays an annual dividend of $2.00 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 88.89%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DFT. What other stocks do shareholders of (DFT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (DFT) investors own include Northrop Grumman (NOC), CyrusOne (CONE), Cisco Systems (CSCO), Antero Resources (AR), Ekso Bionics (EKSO), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), Gilead Sciences (GILD) and Kinder Morgan (KMI). This page (NYSE:DFT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (DFT) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.